This latest twist inside the Lykos Therapeutics saga threatens A serious overhaul of the corporation’s method and direction, with Musk ally and billionaire investor Antonio Gracias appearing to need to just take the business back towards its nonprofit drug progress roots and a more Doblinite philosophy.And also to be honest, it’s not like immed